Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | GIM-531 |
Synonyms | |
Therapy Description |
Limited information is currently available on GIM-531, a putative regulatory T-cell inhibitor (Jun 2024). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
GIM-531 | GIM 531|GIM531 | Limited information is currently available on GIM-531, a putative regulatory T-cell inhibitor (Jun 2024). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06425926 | Phase Ib/II | GIM-531 + unspecified PD-1 antibody GIM-531 | Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors | Recruiting | USA | 0 |